40% of Cancers Are Preventable — Here’s What That Means | Dr. Dino Prato

Six hundred thousand Americans will die from cancer this year, but many of these deaths are preventable.Dr. Prato highlights that early detection and new approaches to cancer prevention could drastically improve outcomes and reduce mortality. We explore the importance of holistic health and effective treatment strategies in oncology to ensure fewer lives are lost to this disease.🎯 What You’ll Learn in This Episode• What the “40% of cancers are preventable” statistic means• Key lifestyle and environmental risk factors• The role of infections in cancer risk• Why early detection improves outcomes• What multi-cancer early detection (MCED) tests are• How metabolic and immune health influence cancer risk• The difference between prevention and treatment strategies• Why individualized approaches are becoming more important📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Prevention and early detection may change the trajectory of cancer care.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493